DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Cannabinol is an investigational drug.
There have been 40 clinical trials for Cannabinol. The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2009.
The most common disease conditions in clinical trials are Marijuana Abuse, Chronic Pain, and Stress Disorders, Traumatic. The leading clinical trial sponsors are Yale University, National Institute on Drug Abuse (NIDA), and Radboud University.
Recent Clinical Trials for Cannabinol
|Cannabis for Acute Migraine: a Randomized, Double-blind, Placebo-controlled, Crossover Trial||Migraine Research Foundation||Phase 2|
|Cannabis for Acute Migraine: a Randomized, Double-blind, Placebo-controlled, Crossover Trial||University of California, San Diego||Phase 2|
|Effects of Pregnancy-associated Hormones on THC Metabolism in Women||National Institute on Drug Abuse (NIDA)||Phase 4|